Letter to the editorRed meat allergy in Sweden: Association with tick sensitization and B-negative blood groups
References (9)
- et al.
Mammalian meat-induced anaphylaxis: clinical relevance of anti-galactose-alpha-1,3-galactose IgE confirmed by means of skin tests to cetuximab
J Allergy Clin Immunol
(2009) - et al.
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose
J Allergy Clin Immunol
(2011) - et al.
Delayed mammalian meat-induced anaphylaxis due to galactose-alpha-1,3-galactose in 5 European patients
J Allergy Clin Immunol
(2011) - et al.
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose
N Engl J Med
(2008)
Cited by (134)
Alpha-Gal Syndrome: A Novel and Increasingly Common Cause of Anaphylaxis
2024, Annals of Emergency MedicineCould mosquito bites facilitate IgE sensitization to food and inhalant allergens?
2024, Medical HypothesesAlpha-Gal IgE Prevalence Patterns in the United States: An Investigation of 3,000 Military Recruits
2024, Journal of Allergy and Clinical Immunology: In PracticeTick salivary glycans – a sugar-coated tick bite
2023, Trends in ParasitologyThe epidemiology of food allergy in adults
2023, Annals of Allergy, Asthma and ImmunologyAscaris lumbricoides and ticks associated with sensitization to galactose α1,3-galactose and elicitation of the alpha-gal syndrome
2022, Journal of Allergy and Clinical Immunology
Supported by research grants from the Swedish Research Council; the Stockholm County Council; the Swedish Heart-Lung Foundation; the Center for Inflammatory Diseases, Karolinska Institutet; the Swedish Asthma and Allergy Association's Research Foundation; the Swedish Cancer and Allergy Foundation; the Konsul Th C Bergs Foundation; the King Gustaf V 80th Birthday Foundation; the Hesselman Foundation; and Karolinska Institutet.
Disclosure of potential conflict of interest: C. Hamsten has received a grant from the Konsul Th C Bergh Foundation. S. P. Commins has received grants from the National Institutes of Health. T. A. E. Platts-Mills has received grants from the National Institute of Allergy and Infectious Diseases (NIAID), has received consulting fees or honoraria from Phadia, has received support for travel to meetings for study or other purposes from ALK-Abelló, has consultant arrangements with IBC/Viracor, and has grants/grants pending with the NIAID. M. van Hage has received one or more grants from the Swedish MRC, the Swedish Heart-Lung Foundation, the Stockholm County Council Research Fund, and the Swedish Asthma and Allergy Association's Research Foundation and has received fees for lectures from Thermo Fisher Scientific, Novartis, and ALK-Abelló. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.